VJHemOnc is committed to improving our service to you

ISA 2020 | DISCOVERY: cardiac amyloidosis screening study

VJHemOnc is committed to improving our service to you

Mathew Maurer

Mathew Maurer, MD, Columbia University, New York, NY, discusses the results of the DISCOVERY screening study (NCT02252653), which investigated the prevalence of TTR mutations in patients suspected of having cardiac amyloidosis. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter